BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23563548)

  • 1. Doxycycline-dependent inducible and reversible RNA interference mediated by a single lentivirus vector.
    Matsushita N; Matsushita S; Hirakawa S; Higashiyama S
    Biosci Biotechnol Biochem; 2013; 77(4):776-81. PubMed ID: 23563548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxycycline regulated lentiviral vectors.
    Markusic D; Seppen J
    Methods Mol Biol; 2010; 614():69-76. PubMed ID: 20225036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral vector-mediated doxycycline-inducible USP39 shRNA or cDNA expression in triple-negative breast cancer cells.
    Liu S; Liu X; Wang H; Zhou Q; Liang Y; Sui A; Yao R; Zhao B; Sun M
    Oncol Rep; 2015 May; 33(5):2477-83. PubMed ID: 25812575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study.
    Pluta K; Diehl W; Zhang XY; Kutner R; Bialkowska A; Reiser J
    BMC Biotechnol; 2007 Jul; 7():41. PubMed ID: 17634114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of all-in-one multicistronic Tet-On lentiviral vectors for inducible co-expression of two transgenes.
    Huang Y; Zhen R; Jiang M; Yang J; Yang Y; Huang Z; Lin Y
    Biotechnol Appl Biochem; 2015; 62(1):48-54. PubMed ID: 24825511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha.
    Aagaard L; Amarzguioui M; Sun G; Santos LC; Ehsani A; Prydz H; Rossi JJ
    Mol Ther; 2007 May; 15(5):938-45. PubMed ID: 17311008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a doxycycline-inducible lentiviral plasmid with an instant regulatory feature.
    Yang T; Burrows C; Park JH
    Plasmid; 2014 Mar; 72():29-35. PubMed ID: 24727543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector.
    Frank SB; Schulz VV; Miranti CK
    BMC Biotechnol; 2017 Feb; 17(1):24. PubMed ID: 28245848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible RNA interference-mediated gene silencing using nanostructured gene delivery arrays.
    Mann DG; McKnight TE; McPherson JT; Hoyt PR; Melechko AV; Simpson ML; Sayler GS
    ACS Nano; 2008 Jan; 2(1):69-76. PubMed ID: 19206549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust, reversible gene knockdown using a single lentiviral short hairpin RNA vector.
    Brown CY; Sadlon T; Gargett T; Melville E; Zhang R; Drabsch Y; Ling M; Strathdee CA; Gonda TJ; Barry SC
    Hum Gene Ther; 2010 Aug; 21(8):1005-17. PubMed ID: 20615123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific knockdown of PPARδ gene in colon cancer cells by lentivirus-mediated RNA interfering.
    Yang L; Zhou ZG; Sun XF
    Methods Mol Biol; 2013; 952():67-86. PubMed ID: 23100225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional gene expression and knockdown using lentivirus vectors encoding shRNA.
    Szulc J; Aebischer P
    Methods Mol Biol; 2008; 434():291-309. PubMed ID: 18470652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vector-based RNA interference to study gene function in cancer.
    Stovall DB; Wan M; Zhang Q; Dubey P; Sui G
    J Vis Exp; 2012 Jun; (64):e4129. PubMed ID: 22710444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versatile Viral Vector Strategies for Postscreening Target Validation and RNAi ON-Target Control.
    Christel CJ; Schmied P; Jagusch V; Schrödel S; Thirion C; Schmitt K; Salomon M
    J Biomol Screen; 2015 Sep; 20(8):976-84. PubMed ID: 25873558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference.
    Wiznerowicz M; Trono D
    J Virol; 2003 Aug; 77(16):8957-61. PubMed ID: 12885912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice.
    Merentie M; Rissanen R; Lottonen-Raikaslehto L; Huusko J; Gurzeler E; Turunen MP; Holappa L; Mäkinen P; Ylä-Herttuala S
    PLoS One; 2018; 13(1):e0190981. PubMed ID: 29351307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The construction of lentivirus-mediated RNAi vector containing hTERT].
    Zhao P; Fu Z; You YP; Wang CZ; Cheng YX; Lu XM; Lu A; Liu N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):27-31. PubMed ID: 18247299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter cross-talk affects the inducible expression of intronic shRNAs from the tetracycline response element.
    Park SK; Hwang BJ; Kee Y
    Genes Genomics; 2019 Apr; 41(4):483-490. PubMed ID: 30656518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable suppression of myostatin gene expression in goat fetal fibroblast cells by lentiviral vector-mediated RNAi.
    Patel UA; Patel AK; Joshi CG
    Biotechnol Prog; 2015; 31(2):452-9. PubMed ID: 25395261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A versatile tool for conditional gene expression and knockdown.
    Szulc J; Wiznerowicz M; Sauvain MO; Trono D; Aebischer P
    Nat Methods; 2006 Feb; 3(2):109-16. PubMed ID: 16432520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.